XML 72 R12.htm IDEA: XBRL DOCUMENT v3.3.0.814
Financial Instruments and Derivatives
9 Months Ended
Oct. 04, 2015
Financial Instruments and Derivatives

E. Financial Instruments and Derivatives

Cash Equivalents

Teradyne considers all highly liquid investments with maturities of three months or less at the date of acquisition to be cash equivalents.

Marketable Securities

Teradyne accounts for its investments in debt and equity securities in accordance with the provisions of Accounting Standards Codification (“ASC”) 320-10, “Investments—Debt and Equity Securities.” ASC 320-10 requires that certain debt and equity securities be classified into one of three categories; trading, available-for-sale or held-to-maturity securities. As of October 4, 2015, Teradyne’s investments in debt and equity securities were classified as available-for-sale and recorded at their fair market value.

On a quarterly basis, Teradyne reviews its investments to identify and evaluate those that have an indication of a potential other-than-temporary impairment. Factors considered in determining whether a loss is other-than-temporary include:

 

    The length of time and the extent to which the market value has been less than cost;

 

    The financial condition and near-term prospects of the issuer; and

 

    The intent and ability to retain the investment in the issuer for a period of time sufficient to allow for any anticipated recovery in market value.

 

Teradyne uses the market and income approach techniques to value its financial instruments and there were no changes in valuation techniques during the three and nine months ended October 4, 2015. As defined in ASC 820-10 “Fair Value Measurements and Disclosures,” fair value is the price that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants. ASC 820-10 requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories:

Level 1: Quoted prices in active markets for identical assets as of the reporting date.

Level 2: Inputs other than Level 1, that are observable either directly or indirectly as of the reporting date. For example, a common approach for valuing fixed income securities is the use of matrix pricing. Matrix pricing is a mathematical technique used to value securities by relying on the securities’ relationship to other benchmark quoted prices, and is considered a Level 2 input.

Level 3: Unobservable inputs that are not supported by market data. Unobservable inputs are developed based on the best information available, which might include Teradyne’s own data.

Teradyne’s available-for-sale fixed income securities are classified as Level 2. Contingent consideration is classified as Level 3. The vast majority of Level 2 securities are priced by third party pricing vendors. These pricing vendors utilize the most recent observable market information in pricing these securities or, if specific prices are not available, use other observable inputs like market transactions involving identical or comparable securities.

Realized losses recorded in the nine months ended October 4, 2015 were $0.2 million. There were no realized losses recorded in the three and nine months ended September 28, 2014. Realized gains recorded in the three and nine months ended October 4, 2015 were $0.4 million and $1.4 million, respectively. Realized gains recorded in the three and nine months ended September 28, 2014 were $1.0 million and $1.7 million, respectively. Realized gains are included in interest income and realized losses are included in interest expense. Unrealized gains and losses are included in accumulated other comprehensive income (loss). The cost of securities sold is based on the specific identification method.

During the nine months ended October 4, 2015 and September 28, 2014, there were no transfers in or out of Level 1, Level 2 or Level 3 financial instruments.

 

The following table sets forth by fair value hierarchy Teradyne’s financial assets and liabilities that were measured at fair value on a recurring basis as of October 4, 2015 and December 31, 2014.

 

     October 4, 2015  
     Quoted Prices
in Active
Markets for
Identical
Instruments
(Level 1)
     Significant
Other
Observable
Inputs
(Level 2)
     Significant
Unobservable
Inputs
(Level 3)
     Total  
     (in thousands)  

Assets

           

Cash

   $ 159,858       $ —        $ —        $ 159,858   

Cash equivalents

     125,879         8,480         —           134,359   

Available-for-sale securities:

           

U.S. Treasury securities

     —           349,653         —           349,653   

U.S. government agency securities

     —           213,491         —           213,491   

Corporate debt securities

     —           114,807         —           114,807   

Certificates of deposit and time deposits

     —           45,677         —           45,677   

Commercial paper

     —           45,510         —           45,510   

Equity and debt mutual funds

     13,377         —           —           13,377   

Non-U.S. government securities

     —           426         —           426   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 299,114       $ 778,044       $ —         $ 1,077,158   
  

 

 

    

 

 

    

 

 

    

 

 

 

Derivative assets

     —           109         —           109   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 299,114      $ 778,153       $ —         $ 1,077,267   
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities

           

Contingent consideration

   $ —         $ —         $ 34,595       $ 34,595   

Derivative liabilities

     —           97         —           97   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ —         $ 97       $ 34,595       $ 34,692   
  

 

 

    

 

 

    

 

 

    

 

 

 

Reported as follows:

 

     (Level 1)      (Level 2)      (Level 3)      Total  
     (in thousands)  

Assets

           

Cash and cash equivalents

   $ 285,737       $ 8,480       $ —         $ 294,217   

Marketable securities

     —           525,381         —           525,381   

Long-term marketable securities

     13,377         244,183         —           257,560   

Prepayments

     —           109         —           109   
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 299,114       $ 778,153       $ —         $ 1,077,267   
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities

           

Other current liabilities

   $ —         $ 97       $ —         $ 97   

Contingent consideration

     —           —           14,447         14,447   

Long-term contingent consideration

     —           —           20,148         20,148   
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ —         $ 97      $ 34,595       $ 34,692   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

     December 31, 2014  
     Quoted Prices
in Active
Markets for
Identical
Instruments
(Level 1)
     Significant
Other
Observable
Inputs
(Level 2)
     Significant
Unobservable
Inputs
(Level 3)
     Total  
     (in thousands)  

Assets

           

Cash

   $ 111,471       $ —         $ —         $ 111,471   

Cash equivalents

     160,218         22,567         —           182,785   

Available-for-sale securities:

           

U.S. Treasury securities

     —           402,154         —           402,154   

U.S. government agency securities

     —           258,502         —           258,502   

Corporate debt securities

     —           141,467         —           141,467   

Commercial paper

     —           140,638         —           140,638   

Certificates of deposit and time deposits

     —           49,036         —           49,036   

Equity and debt mutual funds

     12,333         —           —           12,333   

Non-U.S. government securities

     —           446         —           446   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 284,022       $ 1,014,810       $ —         $ 1,298,832   
  

 

 

    

 

 

    

 

 

    

 

 

 

Derivative assets

     —           220         —           220   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 284,022      $ 1,015,030       $ —         $ 1,299,052   
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities

           

Contingent consideration

   $ —         $ —         $ 3,350       $ 3,350   

Derivative liabilities

     —           369         —           369   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ —         $ 369      $ 3,350       $ 3,719   
  

 

 

    

 

 

    

 

 

    

 

 

 

Reported as follows:

 

     (Level 1)      (Level 2)      (Level 3)      Total  
     (in thousands)  

Assets

           

Cash and cash equivalents

   $ 271,689       $ 22,567       $ —         $ 294,256   

Marketable securities

     —           533,787         —           533,787   

Long-term marketable securities

     12,333         458,456         —           470,789   

Prepayments

     —           220         —           220   
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 284,022       $ 1,015,030       $ —         $ 1,299,052   
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities

           

Other current liabilities

   $ —         $ 369       $ —           369   

Contingent consideration

     —           —           895         895   

Long-term contingent consideration

     —           —           2,455         2,455   
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ —         $ 369       $ 3,350       $ 3,719   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

Changes in the fair value of Level 3 contingent consideration for the three and nine months ended October 4, 2015 and September 28, 2014 were as follows:

 

     For the Three Months
Ended
     For the Nine Months
Ended
 
     October 4,
2015
     September 28,
2014
     October 4,
2015
     September 28,
2014
 
     (in thousands)  

Balance at beginning of period

   $ 35,595       $ 2,230       $ 3,350       $ 2,230   

Acquisition of Universal Robots

     —           —           33,845         —     

Fair value adjustment(a)(b)

     (1,000      (630      (2,600      (630
  

 

 

    

 

 

    

 

 

    

 

 

 

Balance at end of period

   $ 34,595       $ 1,600       $ 34,595       $ 1,600   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(a) In the three and nine months ended October 4, 2015, the fair value of contingent consideration for the earn-out in connection with the acquisition of AIT was reduced by $1.0 million due to a decrease in the revenue probabilities in the periods of 2015 and 2016.
(b) In the nine months ended October 4, 2015, the fair value measurement of the contingent consideration for the earn-out in connection with the acquisition of ZTEC Instruments, Inc. was reduced by $1.6 million, to $0, because Teradyne and the Securityholder Representative, on behalf of the ZTEC securityholders, agreed to terminate the earn-out prior to the end of the December 31, 2015 earn-out period, with no payout in connection with the resolution of indemnity claims asserted by both Teradyne and the Securityholder Representative.

The following table provides quantitative information associated with the fair value measurement of Teradyne’s Level 3 financial instruments:

 

Liability

  October 4,
2015
Fair Value
  Valuation
Technique
 

Unobservable Inputs

  Weighted
Average
 
    (in thousands)              

Contingent consideration

(Universal Robots)

  $33,845   Income approach-
discounted cash
flow
  EBITDA earn-out for calendar year 2015 probability     99
      Discount rate     6.0
      Revenue earn-out for period July 1, 2015—December 31, 2017 probability     72
      Discount rate     8.0
      Revenue earn-out for period July 1, 2015—December 31, 2018 probability     29
      Discount rate     10.0

Contingent consideration

(AIT)

  $750   Income approach-
discounted cash
flow
  Revenue earn-out for calendar years 2015 and 2016 probability     36
      Discount rate     4.7

The significant unobservable inputs used in the Universal Robots fair value measurement of contingent consideration are the probabilities of successful achievement of revenue thresholds and targets in the periods July 1, 2015—December 31, 2017 and July 1, 2015—December 31, 2018 and EBITDA threshold and target for calendar year 2015, and respective discount rates. Increases or decreases in the revenue and EBITDA probabilities and the period in which results will be achieved would result in a higher or lower fair value measurement. The maximum amount of contingent consideration in connection with the acquisition of Universal Robots that could be paid is $65 million. The earn-out periods in connection with the Universal Robots acquisition end on December 31, 2015, December 31, 2017 and December 31, 2018.

The significant unobservable inputs used in the AIT fair value measurement of contingent consideration are the probabilities of successful achievement of calendar year 2015 and 2016 revenue thresholds and targets, and a discount rate. Increases or decreases in the revenue probabilities and the period in which results will be achieved would result in a higher or lower fair value measurement. The maximum amount of contingent consideration in connection with the acquisition of AIT that could be paid is $2.1 million. The earn-out periods in connection with the AIT acquisition end on December 31, 2015 and December 31, 2016.

In the three and nine months ended October 4, 2015, the fair value of contingent consideration for the earn-out in connection with the acquisition of AIT was reduced by $1.0 million due to a decrease in the revenue probabilities in the periods of 2015 and 2016.

The carrying amounts and fair values of Teradyne’s financial instruments at October 4, 2015 and December 31, 2014 were as follows:

 

     October 4, 2015      December 31, 2014  
     Carrying Value      Fair Value      Carrying Value      Fair Value  
     (in thousands)  

Assets

           

Cash and cash equivalents

   $ 294,217       $ 294,217       $ 294,256       $ 294,256   

Marketable securities

     782,941         782,941         1,004,576         1,004,576   

Derivative assets

     109         109         220         220   

Liabilities

           

Contingent consideration

     34,595         34,595         3,350         3,350   

Derivative liabilities

     97         97         369         369   

The fair values of accounts receivable, net and accounts payable approximate the carrying value due to the short-term nature of these instruments.

The following tables summarize the composition of available-for-sale marketable securities at October 4, 2015 and December 31, 2014:

 

     October 4, 2015  
    

 

Available-for-Sale

     Fair Market
Value of
Investments
with Unrealized
Losses
 
     Cost      Unrealized
Gain
     Unrealized
(Loss)
    Fair Market
Value
    
     (in thousands)  

U.S. Treasury securities

   $ 349,464       $ 385       $ (196   $ 349,653       $ 19,260   

U.S. government agency securities

     213,149         342         —          213,491         —     

Corporate debt securities

     115,130         1,305         (1,628     114,807         48,369   

Certificates of deposit and time deposits

     45,652         25        —          45,677         3,505   

Commercial paper

     45,498         12         —          45,510         —     

Equity and debt mutual funds

     12,291         1,183         (97     13,377         1,900   

Non-U.S. government securities

     426         —           —          426         —     
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 
   $ 781,610       $ 3,252       $ (1,921   $ 782,941       $ 73,034   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Reported as follows:

 

     Cost      Unrealized
Gain
     Unrealized
(Loss)
    Fair Market
Value
     Fair Market
Value of
Investments
with Unrealized
Losses
 
     (in thousands)  

Marketable securities

   $ 525,052       $ 335       $ (6   $ 525,381       $ 27,172   

Long-term marketable securities

     256,558         2,917         (1,915     257,560         45,862   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 
   $ 781,610       $ 3,252       $ (1,921   $ 782,941       $ 73,034   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

 

     December 31, 2014  
    

 

Available-for-Sale

     Fair Market
Value of
Investments
with Unrealized
Losses
 
     Cost      Unrealized
Gain
     Unrealized
(Loss)
    Fair Market
Value
    
     (in thousands)  

U.S. Treasury securities

   $ 402,197       $ 362       $ (405   $ 402,154       $ 317,771   

U.S. government agency securities

     258,452         135         (85     258,502         104,642   

Corporate debt securities

     139,374         2,414         (321     141,467         96,998   

Commercial paper

     140,616         26         (4     140,638         41,747   

Certificates of deposit and time deposits

     49,048         11         (23     49,036         20,684   

Equity and debt mutual funds

     10,492         1,870         (29 )     12,333         1,234   

Non-U.S. government securities

     446         —           —          446         —     
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 
   $ 1,000,625       $ 4,818       $ (867   $ 1,004,576       $ 583,076   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Reported as follows:

 

     Cost      Unrealized
Gain
     Unrealized
(Loss)
    Fair Market
Value
     Fair Market
Value of
Investments
with Unrealized
Losses
 
     (in thousands)  

Marketable securities

   $ 533,833       $ 99       $ (145   $ 533,787       $ 240,234   

Long-term marketable securities

     466,792         4,719         (722     470,789         342,842   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 
   $ 1,000,625       $ 4,818       $ (867   $ 1,004,576       $ 583,076   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

As of October 4, 2015, unrealized losses on marketable securities were $1.9 million and the fair market value of investments with unrealized losses was $73.0 million. Of this value, $0.3 million had unrealized losses greater than one year and $72.7 million had unrealized losses less than one year. As of December 31, 2014, unrealized losses on marketable securities were $0.9 million and the fair market value of investments with unrealized losses was $583.1 million. Of this value, $2.3 million had unrealized losses greater than one year and $580.8 million had unrealized losses less than one year.

Teradyne reviews its investments to identify and evaluate investments that have an indication of possible impairment. Based on this review, Teradyne determined that the unrealized losses related to these investments, at October 4, 2015 and December 31, 2014, were temporary.

The contractual maturities of investments held at October 4, 2015 were as follows:

 

     October 4, 2015  
     Cost      Fair Market
Value
 
     (in thousands)  

Due within one year

   $ 525,052       $ 525,381   

Due after 1 year through 5 years

     199,957         200,305   

Due after 5 years through 10 years

     6,075         6,191   

Due after 10 years

     38,235         37,687   
  

 

 

    

 

 

 

Total

   $ 769,319       $ 769,564   
  

 

 

    

 

 

 

Contractual maturities of investments held at October 4, 2015 exclude equity and debt mutual funds as they do not have contractual maturity dates.

 

Derivatives

Teradyne conducts business in a number of foreign countries, with certain transactions denominated in local currencies. The purpose of Teradyne’s foreign currency management is to minimize the effect of exchange rate fluctuations on certain foreign currency denominated monetary assets and liabilities. Teradyne does not use derivative financial instruments for trading or speculative purposes.

To minimize the effect of exchange rate fluctuations associated with the remeasurement of monetary assets and liabilities denominated in foreign currencies, Teradyne enters into foreign currency forward contracts. The change in fair value of these derivatives is recorded directly in earnings, and is used to offset the change in value of monetary assets and liabilities denominated in foreign currencies.

The notional amount of foreign currency forward contracts was $91.5 million and $73.0 million at October 4, 2015 and December 31, 2014, respectively. The fair value of the outstanding contracts was $0.0 million and a loss of $0.1 million at October 4, 2015 and December 31, 2014, respectively.

In the three and nine months ended October 4, 2015, Teradyne recorded a net realized loss of $0.8 million and $2.7 million, respectively, related to foreign currency forward contracts hedging net monetary positions.

In the three months ended September 28, 2014, Teradyne recorded a net realized gain of $0.2 million related to foreign currency forward contracts hedging net monetary positions. In the nine months ended September 28, 2014, Teradyne recorded a net realized loss of $1.6 million related to foreign currency forward contracts hedging net monetary positions. Gains and losses on foreign currency forward contracts and foreign currency remeasurement gains and losses on monetary assets and liabilities are included in other (income) expense, net.

The following table summarizes the fair value of derivative instruments at October 4, 2015 and December 31, 2014:

 

     Balance Sheet Location    October 4,
2015
    December 31,
2014
 
          (in thousands)  

Derivatives not designated as hedging instruments:

       

Foreign exchange contracts assets

   Prepayments    $ 109      $ 220   

Foreign exchange contracts liabilities

   Other current liabilities      (97     (369
     

 

 

   

 

 

 

Total derivatives

      $ 12      $ (149
     

 

 

   

 

 

 

Teradyne’s foreign exchange contracts are subject to master netting agreements.

The following table summarizes the effect of derivative instruments recognized in the statement of operations during the three and nine months ended October 4, 2015 and September 28, 2014. The table does not reflect the corresponding gains and losses from the remeasurement of monetary assets and liabilities denominated in foreign currencies. For the three and nine months ended October 4, 2015, net gains from the remeasurement of monetary assets and liabilities denominated in foreign currencies were $0.1 million and $2.3 million, respectively. For the three months ended September 28, 2014, net losses from the remeasurement of monetary

assets and liabilities denominated in foreign currencies were $0.4 million. For the nine months ended September 28, 2014, net gains from the remeasurement of monetary assets and liabilities denominated in foreign currencies were $0.9 million.

 

    

Location of (Gains) Losses
Recognized in

Statement

of Operations

  For the Three Months
Ended
    For the Nine Months
Ended
 
     October 4,
2015
    September 28,
2014
    October 4,
2015
    September 28,
2014
 
         (in thousands)  

Derivatives not designated as hedging instruments:

          

Foreign exchange contracts

   Other (income) expense, net   $ 677      $ 237      $ 2,555      $ (1,632
    

 

 

   

 

 

   

 

 

   

 

 

 

Total Derivatives

     $ 677      $ 237      $ 2,555      $ (1,632
    

 

 

   

 

 

   

 

 

   

 

 

 

 

See Note F: “Debt” regarding derivatives related to the convertible senior notes.